tirzepatide for menopause New research from a Mayo Clinic–led study suggests that postmenopausal women using hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication overweight and obesity. In Menopause Hormone Therapy May Boost

Nausea can occur but is easily treated

According to data released by the FDA, common Mounjaro side effects include: 1 Nausea Vomiting Diarrhea Constipation Abdominal pain In more severe cases, patients may experience: Kidney damage Diabetic retinopathy Pancreatitis Severe gastrointestinal reactions Acute gallbladder disease Mounjaro has also caused thyroid abnormalities and led to an increased risk of several cancers in animal trials and may cause tumor formation in humans

Cushings syndrome, untreated sleep apnea, and chronic stress (which keeps cortisol elevated) are other potential culprits

Regardless of whether Lilly joins the fray, OFA has an uphill battle in court

These are often transient but can impact quality of life